NO331454B1 - Farmasoytisk preparat for oral administrering omfattende deskarbonyletoksyloratadin - Google Patents

Farmasoytisk preparat for oral administrering omfattende deskarbonyletoksyloratadin Download PDF

Info

Publication number
NO331454B1
NO331454B1 NO20005485A NO20005485A NO331454B1 NO 331454 B1 NO331454 B1 NO 331454B1 NO 20005485 A NO20005485 A NO 20005485A NO 20005485 A NO20005485 A NO 20005485A NO 331454 B1 NO331454 B1 NO 331454B1
Authority
NO
Norway
Prior art keywords
amount
descarbonylethoxyloratadine
pharmaceutical preparation
pharmaceutically acceptable
weight
Prior art date
Application number
NO20005485A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005485D0 (no
NO20005485L (no
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO331454(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20005485D0 publication Critical patent/NO20005485D0/no
Publication of NO20005485L publication Critical patent/NO20005485L/no
Publication of NO331454B1 publication Critical patent/NO331454B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005485A 1998-07-10 2000-10-31 Farmasoytisk preparat for oral administrering omfattende deskarbonyletoksyloratadin NO331454B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10
PCT/US1999/012368 WO2000002560A1 (fr) 1998-07-10 1999-07-08 COMPOSITIONS ORALES DE 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PIRYDINE

Publications (3)

Publication Number Publication Date
NO20005485D0 NO20005485D0 (no) 2000-10-31
NO20005485L NO20005485L (no) 2001-03-09
NO331454B1 true NO331454B1 (no) 2012-01-09

Family

ID=22348307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005485A NO331454B1 (no) 1998-07-10 2000-10-31 Farmasoytisk preparat for oral administrering omfattende deskarbonyletoksyloratadin

Country Status (28)

Country Link
EP (3) EP2055303A3 (fr)
JP (4) JP3224379B1 (fr)
KR (1) KR100420641B1 (fr)
CN (1) CN1145485C (fr)
AR (4) AR016044A1 (fr)
AT (2) ATE432075T1 (fr)
AU (1) AU741201B2 (fr)
BR (1) BR9910449A (fr)
CA (2) CA2377178A1 (fr)
CY (1) CY1109279T1 (fr)
CZ (1) CZ300843B6 (fr)
DE (2) DE69916042T2 (fr)
DK (2) DK1380297T3 (fr)
ES (2) ES2214871T3 (fr)
HK (1) HK1030361A1 (fr)
HU (1) HU228448B1 (fr)
ID (1) ID28645A (fr)
IL (1) IL139407A0 (fr)
MY (1) MY116038A (fr)
NO (1) NO331454B1 (fr)
NZ (2) NZ507885A (fr)
PE (1) PE20000761A1 (fr)
PL (1) PL199390B1 (fr)
PT (2) PT1380297E (fr)
SK (1) SK288240B6 (fr)
TW (1) TW575424B (fr)
WO (1) WO2000002560A1 (fr)
ZA (1) ZA200006224B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
WO2006008512A2 (fr) * 2004-07-16 2006-01-26 Cipla Limited Composition antihistaminique
CA2647605A1 (fr) 2006-03-31 2007-10-11 Research Foundation Itsuu Laboratory Nouveau compose ayant un heterocycle
JP5409382B2 (ja) 2007-11-21 2014-02-05 大日本住友製薬株式会社 口腔内崩壊錠
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
EP2269586B1 (fr) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Composition pharmaceutique comprenant du desloratadine
EP2568970B1 (fr) 2010-05-10 2018-12-05 Laboratorios Lesvi, S.L. Formulations pharmaceutiques stables contenant un antihistaminique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (fr) 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BD PYRIDINE ET SES SELS, LEURS PROCEDES DE PRODUCTION ET COMPOSITIONS PHARMACEUTIQUES CONTENANT SES COMPOSES
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra

Also Published As

Publication number Publication date
DE69916042T2 (de) 2004-11-11
DE69940932D1 (de) 2009-07-09
CY1109279T1 (el) 2012-05-23
CN1145485C (zh) 2004-04-14
WO2000002560A1 (fr) 2000-01-20
CA2377178A1 (fr) 2000-01-20
EP1380297B1 (fr) 2009-05-27
HK1030361A1 (en) 2001-05-04
PT1073438E (pt) 2004-07-30
TW575424B (en) 2004-02-11
JP3224379B1 (ja) 2001-10-29
HU228448B1 (en) 2013-03-28
EP1380297A1 (fr) 2004-01-14
CA2325014C (fr) 2002-05-28
JP4160739B2 (ja) 2008-10-08
NZ512916A (en) 2003-03-28
AR021159A1 (es) 2002-06-12
ATE432075T1 (de) 2009-06-15
NZ507885A (en) 2001-08-31
CN1303284A (zh) 2001-07-11
AU741201B2 (en) 2001-11-22
EP2055303A2 (fr) 2009-05-06
KR20010043402A (ko) 2001-05-25
EP1073438A1 (fr) 2001-02-07
MY116038A (en) 2003-10-31
IL139407A0 (en) 2001-11-25
PT1380297E (pt) 2009-07-06
DK1073438T3 (da) 2004-05-10
HUP0101900A2 (hu) 2001-11-28
PE20000761A1 (es) 2000-08-31
ZA200006224B (en) 2001-11-01
NO20005485D0 (no) 2000-10-31
IL139407A (en) 2001-10-31
JP2005298524A (ja) 2005-10-27
DK1380297T3 (da) 2009-08-17
BR9910449A (pt) 2001-01-02
PL199390B1 (pl) 2008-09-30
AU4953199A (en) 2000-02-01
ID28645A (id) 2001-06-21
CZ20004056A3 (cs) 2001-03-14
DE69916042D1 (de) 2004-05-06
JP2002068983A (ja) 2002-03-08
AR021158A2 (es) 2002-06-12
JP2010265329A (ja) 2010-11-25
ATE262904T1 (de) 2004-04-15
JP4621082B2 (ja) 2011-01-26
EP1073438B1 (fr) 2004-03-31
JP2002520285A (ja) 2002-07-09
CZ300843B6 (cs) 2009-08-26
KR100420641B1 (ko) 2004-03-02
EP2055303A3 (fr) 2009-12-16
NO20005485L (no) 2001-03-09
HUP0101900A3 (en) 2003-01-28
ES2214871T3 (es) 2004-09-16
CA2325014A1 (fr) 2000-01-20
SK17112000A3 (sk) 2001-12-03
PL344045A1 (en) 2001-09-24
AR016044A1 (es) 2001-06-20
AR021157A2 (es) 2002-06-12
ES2326214T3 (es) 2009-10-05
SK288240B6 (sk) 2015-02-03

Similar Documents

Publication Publication Date Title
US6100274A (en) 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
JP4621082B2 (ja) 8−クロロ−6,11−ジヒドロ−11−(4−ピペリジリデン)−5H−ベンゾ[5,6]シクロヘプタ[1,2−b]ピリジンの経口用組成物
NO311918B1 (no) Filmbelagt tablett av astemizol og pseudoefedrin, med forlenget frigivelse, samt fremgangsmåte ved fremstilling av denne
MXPA03005883A (es) Composiciones farmaceuticas que comprenden maleato de amlodipina.
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
CA2804358A1 (fr) Compositions pharmaceutiques contenant de la vanoxerine
CZ20031899A3 (en) Pharmaceutical tablet comprising paroxetine mesylate
MXPA00011159A (en) 8-chloro-6,11-dihydro-11- (4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions
JP4824224B2 (ja) 糖衣製剤
KR101852856B1 (ko) 비타민 d 또는 그 유도체를 함유하는 과립 및 상기 과립과 라록시펜을 포함하는 복합 캡슐제
CS276556B6 (en) Pharmaceutical with a controllable bio-disposal of active component
PL199813B1 (pl) Stały doustny preparat farmaceutyczny acebutololu o przedłużonym uwalnianiu i sposób jego wytwarzania
CZ2005141A3 (cs) Lécivý prípravek na bázi amlodipin-besilátu se zvýsenou stabilitou
SK15612000A3 (sk) Perorálne tablety s riadeným uvoľňovaním farmaceuticky akceptovateľných solí metoprololu a spôsob ich prípravy

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MK1K Patent expired